Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial
Takeda
Meletios A Dimopoulos; Francesca Gay; Fredrik Schjesvold; Meral Beksac; Roman Hajek; Katja Christina Weisel; Hartmut Goldschmidt; Vladimir Maisnar; Philippe Moreau; Chang Ki Min; Agnieszka Pluta; Wee-Joo Chng; Martin Kaiser; Sonja Zweegman; Maria-Victoria Mateos; Andrew Spencer; Shinsuke Iida; Gareth Morgan; Kaveri Suryanarayan; Zhaoyang Teng; Tomas Skacel; Antonio Palumbo; Ajeeta B Dash; Neeraj Gupta; Richard Labotka; S Vincent Rajkumar